Emerging evidence highlights the CD24–Siglec-10 axis as a critical innate immune checkpoint; the engagement of Siglec-10 on macrophages by CD24 transduces a potent anti-phagocytic signal, thereby shielding tumor cells from clearance, particularly in PD-L1-negative TNBC phenotypes. Here, CD24 is linked to neoplasm.